Hansen Gwenn (CIK 1817160) reported 36 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Buy NRIX (1,452 shares), Sell NRIX (1,452 shares), Buy NRIX (4,356 shares), Sell NRIX (1,500 shares), Sell NRIX (2,611 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 1,452 | $2,701 |
| 2026-09-01 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 1,452 | $36,982 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 4,356 | $8,102 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 1,500 | $35,803 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 2,611 | $64,339 |
| 2026-08-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 4,356 | $108,900 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 3,847 | $89,954 |
| 2026-06-25 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 5,394 | $107,880 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,000 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,858 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 3,214 | $53,513 |
| 2026-02-03 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 31,333 | $26,320 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,207 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,000 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,859 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 4,797 | $79,534 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Sell | 98 | $1,702 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,207 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 2,000 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | Buy | 3,750 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01